A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study

Scher, 2011, End points and outcomes in castration-resistant prostate cancer: from clinical trials to clinical practice, J Clin Oncol, 29, 3695, 10.1200/JCO.2011.35.8648 Berry, 1979, Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate, Cancer, 44, 763, 10.1002/1097-0142(197908)44:2<763::AID-CNCR2820440251>3.0.CO;2-5 Emrich, 1985, Prognostic factors in patients with advanced stage prostate cancer, Cancer Res, 45, 5173 Kelly, 1993, Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer, J Clin Oncol, 11, 607, 10.1200/JCO.1993.11.4.607 Halabi, 2003, Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer, J Clin Oncol, 21, 1232, 10.1200/JCO.2003.06.100 Smaletz, 2002, Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration, J Clin Oncol, 20, 3972, 10.1200/JCO.2002.11.021 Alcorta, 2002, Microarray studies of gene expression in circulating leukocytes in kidney diseases, Exp Nephrol, 10, 139, 10.1159/000049909 Bull, 2004, Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension, Am J Respir Crit Care Med, 170, 911, 10.1164/rccm.200312-1686OC Ma, 2003, Gene profiling identifies secreted protein transcripts from peripheral blood cells in coronary artery disease, J Mol Cell Cardiol, 35, 993, 10.1016/S0022-2828(03)00179-2 Osman, 2006, Novel blood biomarkers of human urinary bladder cancer, Clin Cancer Res, 12, 3374, 10.1158/1078-0432.CCR-05-2081 Oh, 2006, Development of an integrated prostate cancer research information system, Clin Genitourin Cancer, 5, 61, 10.3816/CGC.2006.n.019 Rosenberg JE, Ross RW, Wassmann K, et al. Gene expression similarities in whole-blood RNA transcript analysis in geographically disparate prostate cancer populations. ASCO Genitourinary Cancers Symposium 2010; San Francisco, CA, USA; March 5–7, 2010: abstr 181. Ross RW, Bankaitis-Davis D, Siconolfi L, et al. Sensitivity and specificity of a whole-blood RNA transcript-based diagnostic test for the diagnosis of prostate cancer (CaP) compared with prostate-specific antigen (PSA) alone. 44th annual meeting of the American Society of Clinical Oncology; Orlando, FL, USA; May 29–June 2, 2009: abstr 5052. Magidson Hanczar, 2007, Feature construction from synergic pairs to improve microarray-based classification, Bioinformatics, 23, 2866, 10.1093/bioinformatics/btm429 Magidson, 1981, Qualitative variance, entropy, and correlation ratios for nominal dependent variables, Soc Sci Res, 10, 177, 10.1016/0049-089X(81)90003-X Heckman, 1984, A method for minimizing the impact of distributional assumptions in econometric models for duration data, Econometrica, 52, 271, 10.2307/1911491 Land, 2001, Discrete-time hazard regression models with hidden heterogeneity: The semiparametric mixed poisson regression approach, Sociol Methods Res, 29, 342, 10.1177/0049124101029003004 2002, A general latent class approach to unobserved heterogeneity analysis of event history data, 383 McDonald, 2001, Mixture modeling of recurrent event times with long-term survivors: analysis of Hutterite birth intervals, Stat Methods Appl, 10, 257, 10.1007/BF02511651 Steele, 2003, A discrete-time multilevel mixture model for event history data with long-term survivors, with an application to an analysis of contraceptive sterilization in Bangladesh, Lifetime Data Anal, 9, 155, 10.1023/A:1022930918859 Skrondal, 2004 Vermunt, 2005 Schemper, 1996, A note on quantifying follow-up in studies of failure time, Control Clin Trials, 17, 343, 10.1016/0197-2456(96)00075-X Giblin, 2006, LFA-1 as a key regulator of immune function: approaches toward the development of LFA-1-based therapeutics, Curr Pharm Des, 12, 2771, 10.2174/138161206777947731 Hogg, 2003, T-cell integrins: more than just sticking points, J Cell Sci, 116, 4695, 10.1242/jcs.00876 Sierra, 2008, Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages, J Exp Med, 205, 1673, 10.1084/jem.20072602 Smith, 2007, The role of the integrin LFA-1 in T-lymphocyte migration, Immunol Rev, 218, 135, 10.1111/j.1600-065X.2007.00537.x Zipfel, 2004, Requirement for Abl kinases in T cell receptor signaling, Curr Biol, 14, 1222, 10.1016/j.cub.2004.07.021 Chirco, 2006, Novel functions of TIMPs in cell signaling, Cancer Metastasis Rev, 25, 99, 10.1007/s10555-006-7893-x Hornebeck, 2005, Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression, Biochimie, 87, 377, 10.1016/j.biochi.2004.09.022 Lu, 2007, The regulatory roles of C1q, Immunobiology, 212, 245, 10.1016/j.imbio.2006.11.008 Lu, 2008, The classical and regulatory functions of C1q in immunity and autoimmunity, Cell Mol Immunol, 5, 9, 10.1038/cmi.2008.2 Ouellet, 2006, Transcriptional regulation of the cyclin-dependent kinase inhibitor 1A (p21) gene by NFI in proliferating human cells, Nucleic Acids Res, 34, 6472, 10.1093/nar/gkl861 Terheyden, 2005, Human macrophages simultaneously express membrane-C1q and Fc-receptors for IgG, Immunol Lett, 101, 202, 10.1016/j.imlet.2005.06.002 Oh, 2011, Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients, Cancer, 117, 517, 10.1002/cncr.25394 Olmos, 2011, An evaluation of blood mRNA expression array signatures derived from unsupervised analyses in the identification of prostate cancers with poor outcome, Proc Am Soc Clin Oncol, 29, 4577, 10.1200/jco.2011.29.15_suppl.4577 Zhao, 2009, Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling, Cancer Res, 69, 7696, 10.1158/0008-5472.CAN-08-4901 de Bono, 2008, Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer, Clin Cancer Res, 14, 6302, 10.1158/1078-0432.CCR-08-0872